1. Home
  2. ACCO vs FULC Comparison

ACCO vs FULC Comparison

Compare ACCO & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acco Brands Corporation

ACCO

Acco Brands Corporation

HOLD

Current Price

$4.38

Market Cap

353.3M

ML Signal

HOLD

Logo Fulcrum Therapeutics Inc.

FULC

Fulcrum Therapeutics Inc.

SELL

Current Price

$3.70

Market Cap

285.4M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ACCO
FULC
Founded
1893
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Publishing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
353.3M
285.4M
IPO Year
2005
2019

Fundamental Metrics

Financial Performance
Metric
ACCO
FULC
Price
$4.38
$3.70
Analyst Decision
Buy
Hold
Analyst Count
2
5
Target Price
★ $8.00
$3.67
AVG Volume (30 Days)
535.4K
★ 1.2M
Earning Date
10-29-2026
10-28-2026
Dividend Yield
★ 6.91%
N/A
EPS Growth
★ 141.51
N/A
EPS
★ 0.35
N/A
Revenue
★ $1,524,700,000.00
N/A
Revenue This Year
$3.73
N/A
Revenue Next Year
$1.71
N/A
P/E Ratio
$12.40
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.81
$2.83
52 Week High
$4.56
$15.74

Technical Indicators

Market Signals
Indicator
ACCO
FULC
Relative Strength Index (RSI) 58.74 38.13
Support Level $4.15 $3.62
Resistance Level $4.56 $3.91
Average True Range (ATR) 0.11 0.06
MACD 0.01 -0.01
Stochastic Oscillator 100.00 10.26

Price Performance

Historical Comparison
ACCO
FULC

About ACCO Acco Brands Corporation

ACCO Brands Corp is a consumer, technology and business branded products company providing brands and product solutions used in schools, homes and at work. Its brands include At-A-Glance, Barrilito, Buro, Esselte, Five Star, Foroni, GBC, Hilroy, Kensington, Leitz, Mead, PowerA, Quartet, Rapid, Swingline and Tilibra. The Company's product categories include gaming and computer accessories, storage and organization, notebooks, shredding, laminating and binding machines, dry erase boards and do-it-yourself tools. The Company operates through two segments, Americas and International. Americas includes the U.S., Canada, Brazil, Mexico and Chile, and International includes EMEA, Australia, New Zealand and Asia. Its products are sold in the U.S., Europe, Australia, Canada, Brazil and Mexico.

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.

Share on Social Networks: